Coherus Oncology
CHRS
CHRS
116 hedge funds and large institutions have $50.1M invested in Coherus Oncology in 2025 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 40 increasing their positions, 32 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
24% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 17
45% less capital invested
Capital invested by funds: $90.5M → $50.1M (-$40.4M)
Holders
116
Holding in Top 10
–
Calls
$173K
Puts
$67K
Top Buyers
| 1 | +$1.49M | |
| 2 | +$1.17M | |
| 3 | +$437K | |
| 4 |
Renaissance Technologies
New York
|
+$412K |
| 5 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$299K |
Top Sellers
| 1 | -$7.29M | |
| 2 | -$1.54M | |
| 3 | -$782K | |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$441K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$274K |
